The DOI matches its Crossref record; 78 of the 79 references it cites were found in a registry or an index.
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
Open accessAbstract
The biguanide metformin is widely prescribed for Type II diabetes and has anti-neoplastic activity in laboratory models. Despite evidence that inhibition of mitochondrial respiratory complex I by metformin is the primary cause of its cell-lineage-specific actions and therapeutic effects, the molecular interaction(s) between metformin and complex I remain uncharacterized. In the present paper, we describe the effects of five pharmacologically relevant biguanides on oxidative phosphorylation in mammalian mitochondria. We report that biguanides inhibit complex I by inhibiting ubiquinone reduction (but not competitively) and, independently, stimulate reactive oxygen species production by the complex I flavin. Biguanides also inhibit mitochondrial ATP synthase, and two of them inhibit only ATP hydrolysis, not synthesis. Thus we identify biguanides as a new class of complex I and ATP synthase inhibitor. By comparing biguanide effects on isolated complex I and cultured cells, we distinguish three anti-diabetic and potentially anti-neoplastic biguanides (metformin, buformin and phenformin) from two anti-malarial biguanides (cycloguanil and proguanil): the former are accumulated into mammalian mitochondria and affect oxidative phosphorylation, whereas the latter are excluded so act only on the parasite. Our mechanistic and pharmacokinetic insights are relevant to understanding and developing the role of biguanides in new and existing therapeutic applications, including cancer, diabetes and malaria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“inhibition of mitochondrial complex 1 in the electron transport chain and reduction of endogenous production of reactive oxygen species (ROS) (Batandier et al., 2006; Bridges et al., 2014; Zheng et al., 2012)”
From Metformin as a tool to target aging (2016) · cites this paper as Bridges et al., 2014
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“inhibition of mitochondrial complex 1 in the electron transport chain and reduction of endogenous production of reactive oxygen species (ROS) (Batandier et al., 2006; Bridges et al., 2014; Zheng et al., 2012)”
From Metformin as a tool to target aging (2016) · cites this paper as Bridges et al., 2014
In the citing paper
“However, metformin, one of the commonly prescribed drugs for treating type II diabetes, is safe despite acting as a mitochondrial complex I inhibitor that impairs respiration (Bridges et al., 2014; El-Mir et al., 2000; Owen et al., 2000; Wheaton et al., 2014).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Bridges et al., 2014
In the citing paper
“It is also worthy of note that the IC50 for metformin to inhibit mitochondrial complex 1 is 19–66 mM (140, 141).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [141]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo
Zou, M., Kirkpatrick, S. S., Davis, B. J., Nelson, J. S., Wiles, W. G., Schlattner, U., Neumann, D., Brownlee, M., Freeman, M. B., & Goldman, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404421200 · Cited by 480
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Watterson, K. R., Bestow, D., Gallagher, J. R., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2012) · Neurosignals · doi:10.1159/000334144 · Cited by 3,395
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Metformin—mode of action and clinical implications for diabetes and cancer
Pernicova, I., & Korbonits, M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.256 · Cited by 1,393
Partial Resolution of the Enzymes Catalyzing Oxidative Phosphorylation
Kagawa, Y., & Racker, E. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61930-1 · Cited by 1,361
Flagged first, then by citations
1 of the 79 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 661
Coordinate β-adrenergic inhibition of mitochondrial activity and angiogenesis arrest tumor growth
Nuevo‐Tapioles, C., Santacatterina, F., Stamatakis, K., de Arenas, C. N., de Cedrón, M. G., Formentini, L., & Cuezva, J. M. (2020) · Nature Communications · doi:10.1038/s41467-020-17384-1 · Cited by 117
Towards natural mimetics of metformin and rapamycin
Aliper, A. M., Jellen, L. C., Cortese, F., Artemov, A. V., Karpinsky‐Semper, D., Moskalev, A., Swick, A. G., & Zhavoronkov, A. A. (2017) · Aging · doi:10.18632/aging.101319 · Cited by 112
Prattichizzo, F., Giuliani, A., Mensa’, E., Sabbatinelli, J., Nigris, V. D., Rippo, M. R., Sala, L. L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.003 · Cited by 114
Structure of inhibitor-bound mammalian complex I
Bridges, H. R., Fedor, J. G., Blaza, J. N., Luca, A. D., Jussupow, A., Jarman, O. D., Wright, J. J., Agip, A.-N. A., Gámiz‐Hernández, A. P., Roessler, M. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18950-3 · Cited by 108
Self-citationCancer: fundamentals behind pH targeting and the double-edged approach
Koltai, T. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s115438 · Cited by 110
Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases
Huynh, C. Q., Ryu, J., Lee, J., Inoki, A., & Inoki, K. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00648-y · Cited by 109
Pollack, R. M., Barzilai, N., Anghel, V., Kulkarni, A. S., Golden, A., Broin, P. Ó., Sinclair, D. A., Bonkowski, M. S., Coleville, A. J., Powell, D. S., et al. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx041 · Cited by 103
LaMoia, T. E., Butrico, G. M., Kalpage, H. A., Goedeke, L., Hubbard, B. T., Vatner, D. F., Gaspar, R. C., Zhang, X., Cline, G. W., Nakahara, K., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122287119 · Cited by 105
A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes
Barbour, L. A., Scifres, C., Valent, A. M., Friedman, J. E., Buchanan, T. A., Coustan, D., Aagaard, K., Thornburg, K. L., Catalano, P. M., Galan, H. L., et al. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.06.013 · Cited by 101
Detaille, D., Vial, G., Borel, A.-L., Cottet-Rouselle, C., Hallakou-Bozec, S., Bolze, S., Fouqueray, P., & Fontaine, E. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.72 · Cited by 99
Yang, M. H., Darwish, T., Larraufie, P., Rimmington, D., Cimino, I., Goldspink, D. A., Jenkins, B., Koulman, A., Brighton, C. A., Ma, M. K. L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81349-7 · Cited by 103
The effects of metformin on gut microbiota and the immune system as research frontiers
Pollak, M. (2017) · Diabetologia · doi:10.1007/s00125-017-4352-x · Cited by 98
Self-citationThe Pancreatic β-Cell: A Bioenergetic Perspective
Nicholls, D. G. (2016) · Physiological Reviews · doi:10.1152/physrev.00009.2016 · Cited by 100
Fumarate Hydratase Loss Causes Combined Respiratory Chain Defects
Tyrakis, P. A., Yurkovich, M. E., Sciacovelli, M., Papachristou, E. K., Bridges, H. R., Gaude, E., Schreiner, A., D’Santos, C. S., Hirst, J., Hernandez-Fernaud, J. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.092 · Cited by 96
Self-citationMetformin prevents against oxidative stress-induced senescence in human periodontal ligament cells
Kuang, Y., Hu, B., Ge, F., Xiang, M., Deng, Y., Tan, M., Li, J., & Song, J. (2019) · Biogerontology · doi:10.1007/s10522-019-09838-x · Cited by 94
Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities
Li, Z., Zhao, H., & Wang, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.650278 · Cited by 102
AMPK Function in Mammalian Spermatozoa
Martín‐Hidalgo, D., de Llera, A. H., Calle-Guisado, V., González‐Fernández, L., Garcı́a, L. J., & Bragado, M. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113293 · Cited by 100
Hulea, L., Gravel, S., Morita, M., Cargnello, M., Uchenunu, O., Im, Y. K., Lehuédé, C., Ma, E. H., Leibovitch, M., McLaughlan, S., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.001 · Cited by 91
Self-citationMa, L., Wei, J., Wan, J., Wang, W., Wang, L., Yuan, Y., Yang, Z., Liu, X., & Ming, L. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1090-6 · Cited by 89
Rajeshkumar, N. V., Yabuuchi, S., Pai, S. G., Oliveira, E. D., Kamphorst, J. J., Rabinowitz, J. D., Tejero, H., Al‐Shahrour, F., Hidalgo, M. M., Maitra, A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1115 · Cited by 89
MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities
Pedroza‐Torres, A., Romero-Cordoba, S. L., Justo-Garrido, M., Salido-Guadarrama, I., Rodríguez‐Bautista, R., Montaño, S., Muñiz-Mendoza, R., Arriaga-Canon, C., Fragoso‐Ontiveros, V., Álvarez-Gómez, R. M., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01404 · Cited by 93
Hall, D. T., Griss, T., Ma, J. F., Sanchez, B. J., Sadek, J., Tremblay, A. M. K., Mubaid, S., Omer, A., Ford, R. J., Bedard, N., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708307 · Cited by 88
Gupta, P., Bala, M., Gupta, S. K., Dua, A., Dabur, R., Injeti, E. R., & Mittal, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.029 · Cited by 92
Is metformin poised for a second career as an antimicrobial?
Malik, F. R., Mehdi, S. F., Ali, H., Patel, P., Basharat, A., Kumar, A., Ashok, F., Stein, J., Brima, W., Malhotra, P., et al. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2975 · Cited by 89
Mitochondrial Complex I Inhibition by Metformin Limits Reperfusion Injury
Mohsin, A. A., Chen, Q., Quan, N., Rousselle, T. V., Maceyka, M. W., Samidurai, A., Thompson, J., Hu, Y., Li, J., & Lesnefsky, E. J. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.254300 · Cited by 87
Alshawi, A., & Agius, L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006670 · Cited by 87
Syrosingopine sensitizes cancer cells to killing by metformin
Benjamin, D., Colombi, M., Hindupur, S. K., Betz, C., Lane, H. A., El‐Shemerly, M., Lu, M., Quagliata, L., Terracciano, L., Moes, S., et al. (2016) · Science Advances · doi:10.1126/sciadv.1601756 · Cited by 89
Biguanides: Species with versatile therapeutic applications
Kathuria, D., Raul, A. D., Wanjari, P. J., & Bharatam, P. V. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113378 · Cited by 87
New and revisited approaches to preserving the reperfused myocardium
Kloner, R. A., Brown, D. A., CSETE, M. E., Dai, W., Downey, J. M., Gottlieb, R. A., Hale, S. L., & Shi, J. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.102 · Cited by 86
Perioperative Oxidative Stress: The Unseen Enemy
Stevens, J. L., Feelisch, M., & Martín, D. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004455 · Cited by 82
Owen, M. D., Baker, B., SCOTT, E. M., & Forbes, K. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115759 · Cited by 86
Metabolic Profiles Associated With Metformin Efficacy in Cancer
Andrzejewski, S., Siegel, P. M., & St‐Pierre, J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00372 · Cited by 85
Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study
Du, Y., Zhu, Y., Zhou, Y., Ding, J., & Liu, J. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00108-w · Cited by 84
The multifaceted effects of metformin on tumor microenvironment
Kurelac, I., Ganesh, N. U., Iorio, M. C., Porcelli, A. M., & Gasparre, G. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.010 · Cited by 81
Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies
Reyes‐Castellanos, G., Masoud, R., & Carrier, A. (2020) · Biomedicines · doi:10.3390/biomedicines8080270 · Cited by 85
Eukaryotic LYR Proteins Interact with Mitochondrial Protein Complexes
Angerer, H. (2015) · Biology · doi:10.3390/biology4010133 · Cited by 81
Selective Inhibition of Deactivated Mitochondrial Complex I by Biguanides
Matsuzaki, S., & Humphries, K. M. (2015) · Biochemistry · doi:10.1021/bi501473h · Cited by 81
Bridges, H. R., Sirviö, V. A., Agip, A.-N. A., & Hirst, J. (2016) · BMC Biology · doi:10.1186/s12915-016-0287-9 · Cited by 82
Self-citationSumi, C., Okamoto, A., Tanaka, H., Nishi, K., Kusunoki, M., Shoji, T., Uba, T., Matsuo, Y., Adachi, T., Hayashi, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192796 · Cited by 84
Szymczak-Pajor, I., Wenclewska, S., & Śliwińska, A. (2022) · Pharmaceuticals · doi:10.3390/ph15070810 · Cited by 89
Metformin directly targets the H3K27me3 demethylase KDM6A/UTX
Cuyàs, E., Verdura, S., Llorach-Parés, L., Fernández‐Arroyo, S., Luciano‐Mateo, F., Cabré, N., Štursa, J., Werner, L., Martı́n-Castillo, B., Viollet, B., et al. (2018) · Aging Cell · doi:10.1111/acel.12772 · Cited by 80
Rana, P., Aleo, M. D., Gosink, M. M., & Will, Y. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00246 · Cited by 78
Role of Metformin on Osteoblast Differentiation in Type 2 Diabetes
Jiating, L., Buyun, J., & Zhang, Y. (2019) · BioMed Research International · doi:10.1155/2019/9203934 · Cited by 80
Sorrenti, V., Benedetti, F., Buriani, A., Fortinguerra, S., Caudullo, G., Davinelli, S., Zella, D., & Scapagnini, G. (2022) · Pharmaceuticals · doi:10.3390/ph15080912 · Cited by 82
Loubière, C., Clavel, S., Gilleron, J., Harisseh, R., Fauconnier, J., Ben‐Sahra, I., Kaminski, L., Laurent, K., Herkenne, S., Lacas‐Gervais, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05052-2 · Cited by 77
Phenolic compound ellagic acid inhibits mitochondrial respiration and tumor growth in lung cancer
Duan, J., Li, Y., Gao, H., Yang, D., He, X., Fang, Y., & Zhou, G. (2020) · Food & Function · doi:10.1039/d0fo01177k · Cited by 75
Shpakov, A. O. (2021) · Pharmaceuticals · doi:10.3390/ph14010042 · Cited by 83
Lactate and Myocardiac Energy Metabolism
Dong, S., Qian, L., Cheng, Z., Chen, C., Wang, K., Hu, S., Zhang, X., & Wu, T. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.715081 · Cited by 76
Du, K., Ramachandran, A., Weemhoff, J. L., Chavan, H. D., Xie, Y., Krishnamurthy, P. C., & Jaeschke, H. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw158 · Cited by 74
Rico, M., Baglioni, M. V., Bondarenko, M., Laluce, N. C., Rozados, V. R., André, N., Carré, M., Scharovsky, O. G., & Menacho-Márquez, M. (2016) · Oncotarget · doi:10.18632/oncotarget.13760 · Cited by 73
MIF/CD74 axis is a target for novel therapies in colon carcinomatosis
Bozzi, F., Mogavero, A., Varinelli, L., Belfiore, A., Manenti, G., Caccia, C., Volpi, C. C., Beznoussenko, G. V., Milione, M., Leoni, V., et al. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0475-z · Cited by 72
Metabolic reprogramming and disease progression in cancer patients
Torresano, L., Nuevo‐Tapioles, C., Santacatterina, F., & Cuezva, J. M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165721 · Cited by 73
Babak, M. V., Chong, K. R., Rapta, P., Ζαννίκου, Μ., Tang, H. M., Reichert, L., Chang, M. R., Kushnarev, V. A., Heffeter, P., Meier, S. M., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202102266 · Cited by 72
Current topics on inhibitors of respiratory complex I
Murai, M., & Miyoshi, H. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.11.009 · Cited by 73
Vara‐Ciruelos, D., Dandapani, M., Russell, F. M., Grzes, K. M., Atrih, A., Foretz, M., Viollet, B., Lamont, D. J., Cantrell, D. A., & Hardie, D. G. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.067 · Cited by 76
The Mechanism of Action of Biguanides: New Answers to a Complex Question
Magno, L. D., Pastena, F. D., Bordone, R., Coni, S., & Canettieri, G. (2022) · Cancers · doi:10.3390/cancers14133220 · Cited by 81
Cheng, K., & Hao, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122000 · Cited by 70
Skoda, J., Borankova, K., Jansson, P. J., Huang, M., Veselská, R., & Richardson, D. R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.020 · Cited by 72
Urra, F. A., Muñoz, F., Córdova-Delgado, M., Ramírez, M. P., Peña-Ahumada, B., Rios, M., Cruz, P., Ahumada-Castro, U., Bustos, G., Silva-Pavez, E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31367-9 · Cited by 69
Health benefits of late-onset metformin treatment every other week in mice
Alfaras, I., Mitchell, S. J., Mora, H., Lugo, D. R., Warren, A., Navas-Enamorado, I., Hoffmann, V., Hine, C., Mitchell, J. R., Le Couteur, D. G., et al. (2017) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-017-0018-7 · Cited by 68
The Gut Microbiome, Metformin, and Aging
Induri, S. N. R., Kansara, P., Thomas, S. C., Xu, F., Saxena, D. B., & Li, X. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051920-093829 · Cited by 68
mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?
Kezić, A., Popović, L., & Lalic, K. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2640342 · Cited by 68
Reed, S., Taka, E., Darling‐Reed, S., & Soliman, K. F. A. (2025) · Cells · doi:10.3390/cells14141064 · Cited by 76
Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS‐010759
Pujalte‐Martin, M., Belaïd, A., Bost, S., Kahi, M., Peraldi, P., Rouleau, M., Mazure, N. M., & Bost, F. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13583 · Cited by 68
Ochoa-González, F. D. L., Cervantes-Villagrana, A. R., Fernández-Ruiz, J. C., Nava-Ramirez, H. S., Hernandez-Correa, A. C., Enciso‐Moreno, J. A., & Castañeda‐Delgado, J. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150900 · Cited by 64
Tan, J. L., Li, F., Yeo, J. Z. Z., Yong, K. J., Bassal, M. A., Ng, G. H., Lee, M. Y., Leong, C. Y., Tan, H. K., Wu, C.-S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.08.022 · Cited by 64
Murff, H. J., Roumie, C. L., Greevy, R. A., Hackstadt, A. J., McGowan, L. D., Hung, A. M., Grijalva, C. G., & Griffin, M. R. (2018) · Cancer Causes & Control · doi:10.1007/s10552-018-1058-4 · Cited by 65
Metformin prevents the pathological browning of subcutaneous white adipose tissue
Auger, C., Knuth, C. M., Abdullahi, A., Samadi, O., Parousis, A., & Jeschke, M. G. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.011 · Cited by 63
Metformin targets mitochondrial complex I to lower blood glucose levels
Reczek, C. R., Chakrabarty, R. P., D’Alessandro, K. B., Sebo, Z. L., Grant, R. A., Gao, P., Budinger, G. R. S., & Chandel, N. S. (2024) · Science Advances · doi:10.1126/sciadv.ads5466 · Cited by 67
Zhu, J., Zheng, Y., Zhang, H., & Sun, H. (2016) · PubMed Central · Cited by 61
NF-κB and mitochondria cross paths in cancer: mitochondrial metabolism and beyond
Capece, D., Verzella, D., Francesco, B. D., Alesse, E., Franzoso, G., & Zazzeroni, F. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.021 · Cited by 66
Miricescu, D., Bădoiu, S. C., Stănescu-Spînu, I.-I., Totan, A., Ștefani, C., & Greabu, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179512 · Cited by 62
Price, T. J., Das, V., & Dussor, G. O. (2016) · Current Drug Targets · doi:10.2174/1389450116666151102095046 · Cited by 60
Aging, Metabolism, and Cancer Development: from Peto’s Paradox to the Warburg Effect
Tidwell, T., Søreide, K., & Hagland, H. R. (2017) · Aging and Disease · doi:10.14336/ad.2017.0713 · Cited by 64
Totten, S. P., Im, Y. K., Cañedo, E. C., Najyb, O., Nguyen, A., Hébert, S., Ahn, R., Lewis, K., Lebeau, B., Selva, R. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23396-2 · Cited by 63
Self-citationPharmacology of metformin – An update
Glossmann, H. H., & Lutz, O. M. D. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172782 · Cited by 62
OXPHOS inhibitors, metabolism and targeted therapies in cancer
Cadassou, O., & Jordheim, L. P. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115531 · Cited by 59
Sun, Y., Bandi, M. L., Lofton, T. E., Smith, M. G., Bristow, C. A., Carugo, A., Rogers, N. E., Leonard, P. G., Chang, Q., Mullinax, R. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.043 · Cited by 60
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
Fu, Y., Ricciardiello, F., Yang, G., Qiu, J., Huang, H., Xiao, J., Cao, Z., Zhao, F., Liu, Y., Luo, W., et al. (2021) · Cells · doi:10.3390/cells10030497 · Cited by 59
Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies
Amengual-Cladera, E., Morla-Barcelo, P. M., Morán-Costoya, A., Valle, A., Pons, D. G., Sastre‐Serra, J., Roca, P., & Nadal‐Serrano, M. (2024) · Biology · doi:10.3390/biology13050302 · Cited by 74
Weng, Z., Luo, Y., Yang, X., Greenhaw, J. J., Li, H., Xie, L., Mattes, W. B., & Shi, Q. (2014) · Toxicology · doi:10.1016/j.tox.2014.11.002 · Cited by 58
Dragović, S., Vermeulen, N. P. E., Gerets, H. H. J., Hewitt, P. G., Ingelman‐Sundberg, M., Park, B. K., Juhila, S., Snoeys, J., & Weaver, R. J. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1845-1 · Cited by 57
Mitochondrial metabolism and energy sensing in tumor progression
Iommarini, L., Ghelli, A. M., Gasparre, G., & Porcelli, A. M. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.006 · Cited by 58
Targeting Mitochondria to Counteract Age-Related Cellular Dysfunction
Madreiter‐Sokolowski, C. T., Sokolowski, A., Waldeck‐Weiermair, M., Malli, R., & Graier, W. F. (2018) · Genes · doi:10.3390/genes9030165 · Cited by 61
Yang, Y., An, Y., Ren, M., Wang, H., Bai, J., Du, W., & Kong, D. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1243613 · Cited by 56
Metformin Alleviates Altered Erythrocyte Redox Status During Aging in Rats
Garg, G., Singh, S., Singh, A. K., & Rizvi, S. I. (2016) · Rejuvenation Research · doi:10.1089/rej.2016.1826 · Cited by 57
Thummasorn, S., Shinlapawittayatorn, K., Khamseekaew, J., Jaiwongkam, T., Chattipakorn, S. C., & Chattipakorn, N. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.08.001 · Cited by 57
Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence
Vessoni, A. T., Filippi‐Chiela, E. C., Lenz, G., & Batista, L. F. Z. (2019) · Oncogene · doi:10.1038/s41388-019-1128-4 · Cited by 59
Regulation of mitochondrial function as a promising target in platelet activation-related diseases
Eduardo Fuentes, Q., Araya‐Maturana, R., & Urra, F. A. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.007 · Cited by 55
Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozin
Papadopoli, D. J., Uchenunu, O., Palia, R., Chekkal, N., Hulea, L., Topisirović, I., Pollak, M., & St‐Pierre, J. (2021) · Neoplasia · doi:10.1016/j.neo.2021.02.003 · Cited by 54
Self-citationPreventing mitochondrial reverse electron transport as a strategy for cardioprotection
Prag, H. A., Murphy, M. P., & Krieg, T. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-023-01002-4 · Cited by 58
Celestini, V., Tezil, T., Russo, L., Fasano, C., Sanese, P., Forte, G., Peserico, A., Signorile, M. L., Longo, G., Rasmo, D. D., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0336-0 · Cited by 57
Magno, L. D., Manni, S., Pastena, F. D., Coni, S., Macone, A., Cairoli, S., Sambucci, M., Infante, P., Moretti, M., Petroni, M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.024 · Cited by 56
Jankú, F., LoRusso, P. M., Mansfield, A. S., Nanda, R., Spira, A. I., Wang, T., Melhem‐Bertrandt, A., Sugg, J. E., & Ball, H. A. (2021) · Investigational New Drugs · doi:10.1007/s10637-021-01112-7 · Cited by 54
The multifaceted roles of mitochondria at the crossroads of cell life and death in cancer
Fontana, F., & Limonta, P. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.09.024 · Cited by 53
Metformin: A Possible Option in Cancer Chemotherapy
Ugwueze, C. V., Ogamba, O. J., Young, E. E., Onyenekwe, B. M., & Ezeokpo, B. C. (2020) · Analytical Cellular Pathology · doi:10.1155/2020/7180923 · Cited by 52
Biguanides drugs: Past success stories and promising future for drug discovery
Grytsai, O., Myrgorodska, I., Rocchi, S., Ronco, C., & Benhida, R. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113726 · Cited by 51
Xin, G., Wei, Z., Ji, C., Zheng, H., Gu, J., Ma, L., Huang, W., Morris-Natschke, S. L., Yeh, J., Zhang, R., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.018 · Cited by 51
Chuang, C.-H., Dorsch, M., Dujardin, P., Silas, S., Ueffing, K., Hölken, J. M., Yang, D., Winslow, M. M., & Grüner, B. M. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1865 · Cited by 55
Diot, A., Hinks-Roberts, A., Lodge, T., Liao, C., Dombi, E., Morten, K., Brady, S., Fratter, C., Carver, J. G., Muir, R., et al. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.07.014 · Cited by 52
Metadata
- Authors
- Bridges, H. R., Jones, A. J. Y., Pollak, M. N., & Hirst, J.
- Affiliations
- MRC Mitochondrial Biology Unit (GB)
- Department of Oncology, McGill University and Lady Davis Research Institute of the Jewish General Hospital, Montreal, Quebec, Canada, H3T 1E2
- Corresponding author
- Hirst, Judy
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2014-08-22
- Volume
- 462
- Issue
- 3
- Pages
- 475-487
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC4148174
- OpenAlex
- W2012442095
- Cited by
- 661
- References
- 79
- Citations by year
- 2026: 30 · 2025: 53 · 2024: 45 · 2023: 41 · 2022: 61 · 2021: 95 · 2020: 72 · 2019: 66 · 2018: 64 · 2017: 60 · 2016: 43 · 2015: 22 · 2014: 9
- FWCI
- 18.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Biochemical Journal (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Medical Research Council (U105663141)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › ATP Synthase and ATPases Research
- Keywords
- metformin, biguanides, oxidative phosphorylation, mitochondrial complex I, ubiquinone reduction, reactive oxygen species, ATP synthase inhibition, buformin, phenformin, cycloguanil, proguanil, mitochondrial accumulation, type 2 diabetes, anticancer activity, malaria
- MeSH terms
- Animals, Antimalarials, Antineoplastic Agents, Biguanides, Cattle, Proguanil, Diabetes Mellitus, Type 2, Humans, Metformin, Mitochondria, Heart, Mitochondria, Liver, Oxidative Phosphorylation, Plasmodium, Triazines, Reperfusion Injury, Mitochondrial Proton-Translocating ATPases, Electron Transport Complex I, Rats, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
